Total Payments
$15,404
2024 Payments
$789.67
Companies
42
Transactions
393
Medicare Patients
824
Medicare Billing
$121,364
Payment Breakdown by Category
Food & Beverage$10,629 (69.0%)
Other$2,450 (15.9%)
Consulting$2,303 (15.0%)
Education$22.11 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,629 | 382 | 69.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,450 | 5 | 15.9% |
| Consulting Fee | $2,303 | 3 | 15.0% |
| Education | $22.11 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $3,191 | 51 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,751 | 57 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $2,052 | 25 | $0 (2023) |
| Medtronic, Inc. | $816.39 | 24 | $0 (2024) |
| Mannkind Corporation | $712.27 | 23 | $0 (2024) |
| Insulet Corporation | $600.00 | 30 | $0 (2023) |
| Dexcom, Inc. | $577.78 | 17 | $0 (2024) |
| Shire North American Group Inc | $505.56 | 8 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $405.00 | 6 | $0 (2019) |
| Becton, Dickinson and Company | $401.06 | 15 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $789.67 | 32 | Tandem Diabetes Care, Inc. ($159.42) |
| 2023 | $1,172 | 41 | Dexcom, Inc. ($200.39) |
| 2022 | $1,564 | 57 | Novo Nordisk Inc ($333.06) |
| 2021 | $1,983 | 63 | MannKind Corporation ($375.98) |
| 2020 | $2,509 | 43 | Novo Nordisk Inc ($1,738) |
| 2019 | $1,257 | 50 | AstraZeneca Pharmaceuticals LP ($287.06) |
| 2018 | $2,418 | 51 | SANOFI-AVENTIS U.S. LLC ($843.02) |
| 2017 | $3,713 | 56 | AstraZeneca Pharmaceuticals LP ($1,627) |
All Payment Transactions
393 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Diabetes Care | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE 365 SENSOR KIT (RETAIL) (Device) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Diabetes | ||||||
| 11/02/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: Durable Pump | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/30/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/27/2024 | RECORDATI_RARE_DISEASES_INC. | ISTURISA (Drug), SIGNIFOR LAR | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: ENDOCRINE AGENT | ||||||
| 09/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Diabetes | ||||||
| 08/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $105.68 | General |
| Category: Endocrinology | ||||||
| 07/22/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: DIABETES MEDICINE | ||||||
| 07/19/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: Endocrinology | ||||||
| 07/15/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/12/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $31.09 | General |
| Category: Durable Pump | ||||||
| 06/25/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/31/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Diabetes | ||||||
| 05/20/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 05/17/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: Endocrinology | ||||||
| 04/26/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: DIABETES MEDICINE | ||||||
| 04/15/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/12/2024 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $42.72 | General |
| Category: Diabetes | ||||||
| 04/08/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 156 | 226 | $83,164 | $21,191 |
| 2022 | 4 | 186 | 336 | $115,729 | $30,179 |
| 2021 | 4 | 214 | 361 | $110,815 | $35,201 |
| 2020 | 7 | 268 | 438 | $116,918 | $34,793 |
Total Patients
824
Total Services
1,361
Medicare Billing
$121,364
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 82 | 130 | $43,420 | $11,370 | 26.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 36 | 38 | $23,332 | $5,320 | 22.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 46 | $10,304 | $3,079 | 29.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $6,108 | $1,422 | 23.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 173 | $57,782 | $15,797 | 27.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 42 | 44 | $27,016 | $6,586 | 24.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 36 | 104 | $23,296 | $5,826 | 25.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $7,635 | $1,969 | 25.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 112 | 189 | $55,926 | $18,486 | 33.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 39 | 108 | $21,912 | $6,679 | 30.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 36 | 37 | $20,584 | $6,354 | 30.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 27 | 27 | $12,393 | $3,683 | 29.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 117 | 203 | $55,622 | $15,453 | 27.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 39 | 116 | $21,576 | $7,068 | 32.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 30 | 33 | $17,061 | $5,725 | 33.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 25 | 25 | $10,475 | $3,257 | 31.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 33 | 36 | $6,696 | $1,502 | 22.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 12 | 12 | $4,188 | $1,339 | 32.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 12 | 13 | $1,300 | $448.11 | 34.5% |
About Dr. Sofia Vasquez, MD
Dr. Sofia Vasquez, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Hialeah, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1285791350.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sofia Vasquez, MD has received a total of $15,404 in payments from pharmaceutical and medical device companies, with $789.67 received in 2024. These payments were reported across 393 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($10,629).
As a Medicare-enrolled provider, Vasquez has provided services to 824 Medicare beneficiaries, totaling 1,361 services with total Medicare billing of $121,364. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Endocrinology, Diabetes & Metabolism
- Location Hialeah, FL
- Active Since 01/02/2007
- Last Updated 10/29/2024
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1285791350
Products in Payments
- FARXIGA (Drug) $2,064
- RYBELSUS (Drug) $1,739
- AFREZZA (Drug) $712.27
- NO PRODUCT DISCUSSED (Drug) $683.00
- Ozempic (Drug) $629.28
- Omnipod (Device) $600.00
- SOLIQUA (Drug) $569.61
- TOUJEO (Drug) $542.97
- NATPARA (Drug) $397.91
- Rybelsus (Drug) $359.58
- BYDUREON (Drug) $324.73
- MINIMED 770G (Device) $292.05
- STEGLATRO (Drug) $237.63
- t:slim X2 Insulin Pump with Control-IQ (Device) $228.04
- Minimed 770G System (Device) $224.64
- MINIMED 780G (Device) $221.99
- UNITHROID (Drug) $219.60
- LOKELMA (Drug) $211.10
- SOLIQUA 100/33 (Biological) $209.59
- BD Nano (Device) $205.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.